Joint Transnational Call (JTC2018)
- ReCogntiON: Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients fro
- INTEGRALS: INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis
- MSA-Omics: Multi-omics approach to predict therapeutic targets for multiple system atrophy
- IMPACT: Identification of converging Molecular Pathways Across Chromatinopathies as Targets for Therapy
- RAinRARE: Integrated analyses of retinoic acid signaling to understand and treat rare form of progressive motor impairment
- HETER-OMICS: Multi-OMICS interrogation of cerebral cortical malformations
- EUROGLYCAN: Towards a new era for the identification and characterisation of inborn errors of glycosylation
- NARCOMICS: Deciphering the immunopathogenesis of type 1 nacolepsy with omics
- MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease
- LADOMICS: Multi-omics approaches for discovery of new disease mechanisms of LAD-I and LAD-III immunodeficiencies
- i-PAD: Integrative Multi-Omics Analysis of Primary Antibody Deficiency (PAD) Patients for Stratification
- REPETOMICS: Genomic Instability of Expanded Repeats in HD and ALS/FTD
- UltraAIE: Single cell-based ultra high-resolution characterization of intrathecal immunity in Autoimmune Encephalitis